Clinical Research Directory
Browse clinical research sites, groups, and studies.
Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo
Sponsor: Wake Forest University Health Sciences
Summary
We aim to study the impact of perioperative IV lidocaine on postoperative pain control in patients undergoing paraesophageal hernia repair. This is in the context of an established ERAS protocol. We wish to study the effect of IV Lidocaine on postoperative short and long-term outcomes, including patients' length of stay postoperative mortality, morbidity, and quality of life. We will compare this to our standard pain management.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2018-06-21
Completion Date
2026-05
Last Updated
2026-02-03
Healthy Volunteers
Yes
Conditions
Interventions
IV lidocaine
Patients randomized to the IV lidocaine group will receive a 100 mg lidocaine bolus on induction then an infusion of 1.5 mg/kg/hr prior to incision. This infusion will continue throughout operation and into the PACU for 1 hour OR until the 2gm/250 mL D5W bag has been infused, whichever occurs first.
Placebo
o Patients randomized to the placebo group will receive D5W solution (as this is the carrier for lidocaine) at the same volume and rate as the IV lidocaine.
Locations (1)
Atrium Health - Carolinas Medical Center
Charlotte, North Carolina, United States